TY - JOUR
T1 - Histologic grading study of prostate adenocarcinoma
T2 - The development of a new system and comparison with other methods—A preliminary study
AU - Brawn, Peter N.
AU - Ayala, Alberto G.
AU - Von Eschenbach, Andrew C.
AU - Hussey, David H.
AU - Johnson, Douglas E.
PY - 1982/2/1
Y1 - 1982/2/1
N2 - A new grading system for adenocarcinoma of the prostate (MDAH System) and its simplified version, both based on the percentage of tumor that is differentiated (gland-forming) or undifferentiated (non-gland-forming), were compared with the grading systems of Mostofi and Gleason. In a study group of 182 patients with Stage C adenocarcinoma of the prostate, the MDAH system identified 84 patients (46%) as Grade 1, 75 (41%) as Grade 2-3, and 23 (13%) as Grade 4. Kaplan-Meier survival curves predicted a 91% five-year survival for Grade 1 patients, a 60% 5-year survival for Grade 2-3 patients, and a 15% five-year survival for Grade 4 patients. Wilcoxon (Gehan modification) tests showed that the survival was significantly different among Grades 1, 2-3, and 4. The MDAH System is an improvement over other grading systems in that it is a simple, low-power microscopic method that depends only on the percentage of gland formation in the tumor and further reflects the biologic behavior of the tumor as measured by the patient's survival.
AB - A new grading system for adenocarcinoma of the prostate (MDAH System) and its simplified version, both based on the percentage of tumor that is differentiated (gland-forming) or undifferentiated (non-gland-forming), were compared with the grading systems of Mostofi and Gleason. In a study group of 182 patients with Stage C adenocarcinoma of the prostate, the MDAH system identified 84 patients (46%) as Grade 1, 75 (41%) as Grade 2-3, and 23 (13%) as Grade 4. Kaplan-Meier survival curves predicted a 91% five-year survival for Grade 1 patients, a 60% 5-year survival for Grade 2-3 patients, and a 15% five-year survival for Grade 4 patients. Wilcoxon (Gehan modification) tests showed that the survival was significantly different among Grades 1, 2-3, and 4. The MDAH System is an improvement over other grading systems in that it is a simple, low-power microscopic method that depends only on the percentage of gland formation in the tumor and further reflects the biologic behavior of the tumor as measured by the patient's survival.
UR - http://www.scopus.com/inward/record.url?scp=0020042959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020042959&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(19820201)49:3<525::AID-CNCR2820490321>3.0.CO;2-M
DO - 10.1002/1097-0142(19820201)49:3<525::AID-CNCR2820490321>3.0.CO;2-M
M3 - Article
C2 - 7037148
AN - SCOPUS:0020042959
SN - 0008-543X
VL - 49
SP - 525
EP - 532
JO - Cancer
JF - Cancer
IS - 3
ER -